Nelfinavir

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1940 publications

An Overview of the Mechanisms of HPV-Induced Cervical Cancer: The Role of Kinase Targets in Pathogenesis and Drug Resistance.

An Overview of the Mechanisms of HPV-Induced Cervical Cancer: The Role of Kinase Targets in Pathogenesis and Drug Resistance.

Journal: Cancers

Published: November 06, 2025

NIBAN2/FLII/RREB1 Axis Drives Glioma Stem Cell Malignancy via TLR3 Pathway Activation.

NIBAN2/FLII/RREB1 Axis Drives Glioma Stem Cell Malignancy via TLR3 Pathway Activation.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 05, 2025

Molecular docking and dynamic simulation of marine natural products from soft coral-derived microbes against SARS-CoV-2 main protease and spike protein.

Molecular docking and dynamic simulation of marine natural products from soft coral-derived microbes against SARS-CoV-2 main protease and spike protein.

Journal: Scientific reports

Published: July 06, 2025

Darunavir analog precursors target mitochondrial metabolism in multiple myeloma and CLL.

Darunavir analog precursors target mitochondrial metabolism in multiple myeloma and CLL.

Journal: Cancer cell international

Published: June 06, 2025

Insights into Antiviral Candidates against Oropouche Virus: A Molecular Dynamics Study.

Insights into Antiviral Candidates against Oropouche Virus: A Molecular Dynamics Study.

Journal: ACS physical chemistry Au

Published: May 23, 2025

Forecasting drug resistant HIV protease evolution.

Forecasting drug resistant HIV protease evolution.

Journal: PLoS computational biology

Published: April 21, 2025

Nelfinavir triggers ferroptosis by inducing ER stress mediated downregulation of GPX4/GSH system, upregulation of NRF2/HO-1 axis, and mitochondrial impairment in hepatocellular carcinoma cells.

Nelfinavir triggers ferroptosis by inducing ER stress mediated downregulation of GPX4/GSH system, upregulation of NRF2/HO-1 axis, and mitochondrial impairment in hepatocellular carcinoma cells.

Journal: Cell death discovery

Published: April 18, 2025

Harnessing p53 for targeted cancer therapy: new advances and future directions.

Harnessing p53 for targeted cancer therapy: new advances and future directions.

Journal: Transcription

Published: March 03, 2025

Repurposing of approved drugs towards Nipah virus treatment: an in silico docking, molecular dynamics simulation and a MM/GBSA approach.

Repurposing of approved drugs towards Nipah virus treatment: an in silico docking, molecular dynamics simulation and a MM/GBSA approach.

Journal: In silico pharmacology

Published: February 23, 2025

Potency-enhancing mutations in E3-19K and i-leader increase the cytolytic activity of the PH20/SPAM1-armed oncolytic adenovirus Ad5Δ24RGD.

Potency-enhancing mutations in E3-19K and i-leader increase the cytolytic activity of the PH20/SPAM1-armed oncolytic adenovirus Ad5Δ24RGD.

Journal: Molecular therapy. Oncology

Published: February 23, 2025

Risk Assessment for Drug-Induced Hyperbilirubinemia: A Mechanistic Approach.

Risk Assessment for Drug-Induced Hyperbilirubinemia: A Mechanistic Approach.

Journal: CPT: pharmacometrics & systems pharmacology

Published: February 18, 2025

Insights into the interaction mechanism of first-generation HIV-1 protease inhibitors with wild-type and mutant (D30N and L76V) enzymes through in-silico based approach.

Insights into the interaction mechanism of first-generation HIV-1 protease inhibitors with wild-type and mutant (D30N and L76V) enzymes through in-silico based approach.

Journal: Journal of biomolecular structure & dynamics

Published: February 17, 2025

Showing 1-12 of 1,940

Last Updated: 04/28/2026